基于CT影像学参数探讨肾周脂肪对肾癌诊断与预后判断的临床意义

芮晨宇, 樊伟林, 孙巍, 等. 基于CT影像学参数探讨肾周脂肪对肾癌诊断与预后判断的临床意义[J]. 临床泌尿外科杂志, 2023, 38(12): 929-933. doi: 10.13201/j.issn.1001-1420.2023.12.008
引用本文: 芮晨宇, 樊伟林, 孙巍, 等. 基于CT影像学参数探讨肾周脂肪对肾癌诊断与预后判断的临床意义[J]. 临床泌尿外科杂志, 2023, 38(12): 929-933. doi: 10.13201/j.issn.1001-1420.2023.12.008
RUI Chenyu, FAN Weilin, SUN Wei, et al. Correlation between the diagnosis and prognosis of renal carcinoma and perirenal adipose based on parameters in CT imaging[J]. J Clin Urol, 2023, 38(12): 929-933. doi: 10.13201/j.issn.1001-1420.2023.12.008
Citation: RUI Chenyu, FAN Weilin, SUN Wei, et al. Correlation between the diagnosis and prognosis of renal carcinoma and perirenal adipose based on parameters in CT imaging[J]. J Clin Urol, 2023, 38(12): 929-933. doi: 10.13201/j.issn.1001-1420.2023.12.008

基于CT影像学参数探讨肾周脂肪对肾癌诊断与预后判断的临床意义

  • 基金项目:
    研究生科研创新计划项目(No: Byycx22132)
详细信息

Correlation between the diagnosis and prognosis of renal carcinoma and perirenal adipose based on parameters in CT imaging

More Information
  • 目的 探究肾周脂肪CT参数对肾癌诊断和预后的临床意义和预测价值。方法 收集蚌埠医学院第一附属医院泌尿外科肾癌患者91例,同时收集50例肾囊肿患者作为对照。记录2组患者一般临床资料、MAP评分、肾周脂肪CT值、厚度和面积等资料,寻找对肾癌诊断具有临床意义的指标并分析其与肾癌患者预后的相关性。结果 2组患者的患侧肾周脂肪面积及手术时间比较差异有统计学意义(P<0.05)。回归分析结果显示,患侧肾周脂肪面积与肾癌相关(P<0.05),且为肾癌发生的独立危险因素。ROC曲线分析结果显示,在肾癌组与肾囊肿组中,最佳临界值为14.575,灵敏度为63.7%,特异度为64.0%,约登指数为0.277,ROC曲线下面积为0.634。在肾癌复发组与未复发组中,最佳临界值为21.485,灵敏度为100.0%,特异度为65.5%,约登指数为0.655,ROC曲线下面积为0.731。免疫组化结果表明高面积组解偶连蛋白1(uncoupling protein 1,UCP-1)表达显著高于低面积组。结论 本研究证实患侧肾周脂肪面积在肾癌诊断及预后判断方面具有一定的临床价值,值得关注并推广。
  • 加载中
  • 图 1  肾周脂肪厚度

    图 2  肾周脂肪面积及密度

    图 3  患侧肾周脂肪面积对肾癌诊断的ROC曲线

    图 4  患侧肾周脂肪面积对肾癌预后的ROC曲线

    图 5  肾周脂肪UCP-1的表达

    表 1  肾癌组和肾囊肿组资料比较 例(%),X±SM(Q1Q3)

    参数 肾癌组(91例) 肾囊肿组(50例) P
    年龄/岁 56(31,79) 58(30,77) 0.866
    性别 0.627
      男 53(58.21) 27(54.00)
      女 38(41.76) 23(46.00)
    糖尿病 13(14.29) 3(6.00) 0.138
    高血压 44(48.35) 19(38.00) 0.237
    术前肌酐/(μmol/L) 74(63.00,83.00) 67(57.00,76.75) 0.059
    MAP评分 0.496
      轻 38(41.76) 22(44.00)
      中 31(34.06) 20(40.00)
      重 22(24.18) 8(16.00)
    肿物直径/mm 4.69±1.43 4.67±1.23 0.948
    手术时间/min 91.71±26.37 64.36±13.11 <0.001
    患侧肾周脂肪CT值 -85.70(-93.70,-78.40) -88.90(-94.35,-82.15) 0.277
    健侧肾周脂肪CT值 -86.50(-93.30,-77.70) -87.95(-95.03,-79.60) 0.620
    患侧肾周脂肪厚度/cm 1.35±0.70 1.37±0.88 0.102
    健侧肾周脂肪厚度/cm 1.13±0.60 1.13(0.60,1.82) 0.651
    双侧肾周脂肪厚度之和/cm 2.48±1.20 2.24(1.26,3.72) 0.928
    患侧肾周脂肪面积/cm2 18.64±9.79 12.18(4.41,22.80) 0.009
    健侧肾周脂肪面积/cm2 15.95±8.99 11.04(5.98,20.55) 0.115
    双侧肾周脂肪面积之和/cm2 34.59±18.64 28.23±21.17 0.067
    下载: 导出CSV

    表 2  2组间单因素和多因素logistic回归分析

    因素 单因素分析 多因素分析
    OR(95%CI) P OR(95%CI) P
    年龄 1.006(0.974~1.038) 0.727
    性别 0.842(0.420~1.686) 0.627
    糖尿病 2.611(0.707~9.644) 0.150
    高血压 1.527(0.756~3.087) 0.238
    术前肌酐 1.022(0.999~1.046) 0.055
    MAP评分 1.194(0.759~1.879) 0.443
    肿物直径 1.009(0.782~1.301) 0.947
    手术时间 0.987(0.975~0.999) 0.035 0.984(0.972~0.997) 0.015
    患侧肾周脂肪CT值 1.017(0.987~1.048) 0.265
    健侧肾周脂肪CT值 0.995(0.979~1.012) 0.576
    患侧肾周脂肪厚度 0.973(0.620~1.527) 0.906
    健侧肾周脂肪厚度 0.738(0.454~1.202) 0.223
    双侧肾周脂肪厚度之和 0.917(0.716~1.174) 0.491
    患侧肾周脂肪面积 1.040(1.004~1.078) 0.030 1.048(1.009~1.088) 0.014
    健侧肾周脂肪面积 1.018(0.979~1.057) 0.371
    双侧肾周脂肪面积之和 1.015(0.997~1.035) 0.108
    下载: 导出CSV
  • [1]

    Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. doi: 10.3322/caac.21654

    [2]

    Lin WH, Yang ZG, Yan L, et al. Comparison of partial nephrectomy and radical nephrectomy for cystic renal cell carcinoma: a SEER-based and retrospective study[J]. Sci Rep, 2023, 13(1): 8052. doi: 10.1038/s41598-023-34950-x

    [3]

    Lucocq J, Pillai S, Oparka R, et al. Complex renal cysts(Bosniak ≥ⅡF): interobserver agreement, progression and malignancy rates[J]. Eur Radiol, 2021, 31(2): 901-908. doi: 10.1007/s00330-020-07186-w

    [4]

    胡威, 祝恒成. 囊性肾癌的诊断和治疗现状分析[J]. 现代泌尿生殖肿瘤杂志, 2022, 14(3): 129-132. https://www.cnki.com.cn/Article/CJFDTOTAL-PXDM202203001.htm

    [5]

    Huang HC, Chen S, Li W, et al. High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma[J]. Urol Oncol, 2018, 36(4): 157.e1-157.e6. doi: 10.1016/j.urolonc.2017.12.011

    [6]

    翁同辉, 任轲, 陈晗, 等. 内脏脂肪面积与肾癌病理分型及分级的相关性[J]. 现代泌尿外科杂志, 2021, 26(4): 322-327.

    [7]

    Li XQ, Wang GC, Liu J, et al. Increased UCP1 expression in the perirenal adipose tissue of patients with renal cell carcinoma[J]. Oncol Rep, 2019, 42(5): 1972-1980.

    [8]

    Jovanović M, Kovačević S, Brkljačić J, et al. Oxidative Stress Linking Obesity and Cancer: Is Obesity a 'Radical Trigger' to Cancer?[J]. Int J Mol Sci, 2023, 24(9): 8452. doi: 10.3390/ijms24098452

    [9]

    Roopakala MS, Suresh A, Ashtalakshmi, et al. Anthropometric measurements as predictors of intraabdominal fat thickness[J]. Indian J Physiol Pharmacol, 2009, 53(3): 259-264.

    [10]

    Wu HY, Xu SY, Chen LL, et al. Waist to height ratio as a predictor of abdominal fat distribution in men[J]. Chin J Physiol, 2009, 52(6): 441-445. doi: 10.4077/CJP.2009.AMH064

    [11]

    Kojima S, Usui N, Shigetake M, et al. Intramuscular and abdominal fat measured by computed tomography and mortality of hemodialysis patients[J]. Nephrol Dial Transplant, 2023: gfad169. doi: 10.1093/ndt/gfad169

    [12]

    Vural M, Akdal Dolek B, Ucar O, et al. The evaluation of subcutaneous and visceral adipose tissue changes by computed tomography in coronavirus disease 2019 and comparison with quantitative analysis of lung involvement[J]. Curr Med Imaging, 2023.

    [13]

    Jespersen NZ, Feizi A, Andersen ES, et al. Heterogeneity in the perirenal region of humans suggests presence of dormant brown adipose tissue that contains brown fat precursor cells[J]. Mol Metab, 2019, 24: 30-43. doi: 10.1016/j.molmet.2019.03.005

    [14]

    Adamczak M, Wiecek A. The adipose tissue as an endocrine organ[J]. Semin Nephrol, 2013, 33(1): 2-13. doi: 10.1016/j.semnephrol.2012.12.008

    [15]

    Di WJ, Zhang WL, Zhu B, et al. Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR-146b-5p[J]. J Cell Physiol, 2021, 236(7): 5399-5410. doi: 10.1002/jcp.30245

    [16]

    Zhang HY, Zhu L, Bai M, et al. Exosomal circRNA derived from gastric tumor promotes white adipose browning by targeting the miR-133/PRDM16 pathway[J]. Int J Cancer, 2019, 144(10): 2501-2515. doi: 10.1002/ijc.31977

    [17]

    Wei G, Sun HL, Dong K, et al. The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy[J]. Cell Metab, 2021, 33(10): 2021-2039.e8. doi: 10.1016/j.cmet.2021.08.012

    [18]

    Aurilio G, Piva F, Santoni M, et al. The role of obesity in renal cell carcinoma patients: clinical-pathological implications[J]. Int J Mol Sci, 2019, 20(22): 5683. doi: 10.3390/ijms20225683

    [19]

    Fan WL, Yeh YM, Liu TT, et al. Leptin is associated with poor clinical outcomes and promotes clear cell renal cell carcinoma progression[J]. Biomolecules, 2021, 11(3): 431. doi: 10.3390/biom11030431

    [20]

    Sun GX, Zhang XM, Liu ZH, et al. The adiponectin-AdipoR1 axis mediates tumor progression and tyrosine kinase inhibitor resistance in metastatic renal cell carcinoma[J]. Neoplasia, 2019, 21(9): 921-931. doi: 10.1016/j.neo.2019.07.004

  • 加载中

(5)

(2)

计量
  • 文章访问数:  783
  • PDF下载数:  304
  • 施引文献:  0
出版历程
收稿日期:  2023-05-31
刊出日期:  2023-12-06

目录